Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 48, 2008, Pages 18976-18981

  Baganz, Nicole L ^a   Hortona, Rebecca E ^a   Calderon, Alfredo S ^a   Owens, W Anthony ^a   Munn, Jaclyn L ^a   Watts, Lora T ^a   Koldzic Zivanovic, Nina ^a   Jeske, Nathaniel A ^a   Koek, Wouter ^a,b   Toney, Glenn M ^a   Daws, Lynette C ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

5HTTLPR; Antidepressant; Chronamperometry; Hippocampus; Polymorphism

Indexed keywords

ANTIDEPRESSANT AGENT; ORGANIC CATION TRANSPORTER 3; SEROTONIN; SEROTONIN TRANSPORTER;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR THERAPY; CONTROLLED STUDY; DRUG ACTIVITY; EXPERIMENTAL MOUSE; IN VIVO STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; MOUSE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; EXTRACELLULAR SPACE; GENOTYPE; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, INBRED C57BL; ORGANIC CATION TRANSPORT PROTEINS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA; MUS;

EID: 57749087000     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0800466105     Document Type: Article

References (56)

1. Blakely RD, et al. (1998) Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry 44:169-178.
2. Lesch KP, et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
3. Feinn R, Nellissery M, Kranzler HR (2005) Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B 133:79-84.
4. Wurtman RJ (2005) Genes, stress and depression. Metabolism 54:16-19.
5. Hariri AR, Drabant EM, Weinberger DR (2006) Imaging genetics: Perspectives from studies of genetically driven variation in serotonin transporter function and corticolimbic affective processing. Biol Psychiatry 59:888-897.
6. Rausch JL (2005) Initial conditions of psychotropic drug response: Studies of serotonin transporter long promoter region (5-HTTLPR), serotonin transporter efficiency, cytokine and kinase gene expression relevant to depression and antidepressant outcome. Prog Neuropsychopharmacol Biol Psychiatry 29:1046-1061.
7. Daws LC, et al. (2006) Ethanol inhibits clearance of brain serotonin by a serotonin transporter independent mechanism. J Neurosci 26:6431-6438.
8. Shaskan EG, Snyder SH (1970) Kinetics of serotonin accumulation into slices from rat brain: Relationship to catecholamine uptake. J Pharmacol Exp Ther 175:404-418.
9. Jackson BP, Wightman RM (1995) Dynamics of 5-hydroxytryptamine released from dopamine neurons in caudate putamen of the rat. Brain Res 674:163-166.
10. Pan Y, et al. (2001) Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice. Brain Res Dev Brain Res 126:125-129.
11. Zhou FC, Lesch KP, Murphy DL (2002) Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Brain Res 942:109-119.
12. Callaghan PD, Irvine RJ, Daws LC (2005) Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochem Int 47:350-361.
13. Daws LC, et al. (2005) Transport mechanisms governing clearance in vivo revealed by high-speed chronoamperometry. J Neurosci Meth 143:49-62.
14. Zhou FM, et al. (2005) Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron 46:65-74.
15. Montañez S, Owens WA, Gould GG, Murphy DL, Daws LC (2003) Exaggerated effects of fluvoxamine in heterozygote serotonin transporter knockout mice. J Neurochem 86:210-219.
16. Busch AE, et al. (1996) Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1. FEBS Lett 395:153-156.
17. Koepsell H, Lips K, Volk C (2007) Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24:1227-1251.
18. Wu X, et al. (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake 2) and evidence for the expression of the transporter in brain. J Biol Chem 273:32776-32786.
19. Amphoux A, et al. (2006) Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 50:941-952.
20. Gasser PJ, Lowry CA, Orchinik M (2006) Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: Potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci 26:8758-8766.
21. Fujimoto Y, et al. (2007) The pharmacokinetic properties of methamphetamine in rats with previous repeated exposure to methamphetamine: The difference between Long-Evans and Wistar rats. Exp Anim 56:119-129.
22. Feng N, et al. (2005) Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus. Brain Res 1063:69-76.
23. Chen JJ, et al. (2001) Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intenstinal motility and the expression of cation transporters. J Neurosci 21:6348-6361.
24. Schmitt A, et al. (2003) Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. J Neurosci Res 71:701-709.
25. Campell S, Macqueen G (2004) The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 29:417-426.
26. Vialou V, Amphoux A, Zwart R, Giros B, Gautron S (2004) Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci 24:2846-2851.
27. Gorboulev V, et al. (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871-881.
28. Alnouti Y, Petrick JS, Klaassen CD (2006) Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab Dispos 34:477-482.
29. Gründemann D, Schechinger B, Rappold GA, Schömig E (1998) Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 5:349-351.
30. Zhou FC, Xu Y, Bledsoe S, Lin R, Kelley MR (1996) Serotonin transporter antibodies: Production, characterization, and localization in the brain. Brain Res Mol Brain Res 43:267-278.
31. Iritani S, Tohgi M, Arai T, Ikeda K (2006) Immunohistochemical study of the serotonergic neuronal system in an animal model of the mood disorder. Exp Neurol 201:65.
32. Schomig E, Babin-Ebell J, Russ H (1993) 1,1′-diethyl-2,2′- cyanine (decynium22) potently inhibits the renal transport of organic cations. Naunyn Schmiedebergs Arch Pharmacol 347:379-383.
33. Daws LC, Toney GM (2007) Voltammetric Methods to Study Kinetics and Mechanisms for Serotonin Clearance In Vivo. Electrochemical Methods in Neuroscience, for Methods and New Frontiers in Neuroscience, eds Michael AC, Simon SA, Nicolelis MAL (CRC, Boca Raton, FL), pp 63-81.
34. Daws LC (2008) Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther, 10.1016/j.pharmthera.2008.10.004.
35. Gerhardt GA, Palmer MR (1987) Characterization of the techniques of pressure ejection and microiontophoresis using in vivo electrochemistry. J Neurosci Meth 22:147-159.
36. Engel K, Zhou M, Wang J (2004) Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279:50042-50049.
37. Schildkraut JJ, Mooney JJ (2004) Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis. Am J Psychiatry 161:909-911.
38. Cryan JF, Holmes A (2005) The ascent of the mouse: Advances in modeling human depression and anxiety. Nature Rev 4:775-790.
39. Holmes A, Yang RJ, Murphy DL, Crawley JN (2002) Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27:914-923.
40. Swiergiel AH, Leskov IL, Dunn AJ (2007) Effects of chronic and acute stressors and CRF on depression-like behavior in mice. Behav Brain Res, 10.1016/j.bbr. 2007.07.018.
41. Stone EA, Lin Y (2008) An anti-immobility effect of exogenous corticosterone in mice. Eur J Pharmacol 580:135-142.
42. Aoyama N, et al. (2006) Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. Alchol Clin Exp Res 30:1644-1649.
43. Vialou V, et al. (2008) Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J Neurochem 106:1471-1482.
44. Gaspar P, Cases O, Maroteaux L (2003) The developmental role of serotonin: News from mouse molecular genetics. Nat Rev Neurosci 4:1002-1012.
45. Sutcliffe JS, et al. (2005) Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet 77:265-279.
46. Serretti A, Kato M, De Ronchi D, Kinoshita T (2007) Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiat 12:247-257.
47. Kitaichi K, et al. (2005) Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice. Neurosci Lett 382:195-200.
48. Hirano K, et al. (2005) Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain. Brain Res 1053:154-161.
49. Mirza NR, Nielsen EO, Troelsen KB (2007) Serotonin transporter density and anxiolytic-like effects of antidepressants in mice. Prog Neuropsychopharmacol Biol Psychiatry 31:843-866.
50. Iceta R, Mesonero JE, Alcalde AI (2007) Effects of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells. Life Sci 80:1517-1524.
51. Lau T, Horschitz S, Berger S, Bartsch D, Schloss P (2008) Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons. FASEB J, 10.1096/fj.07-095471.
52. Bengel D, et al. (1998) Altered brain serotonin (5-HT) homeostasis and locomotor insensitivity to MDMA ("ecstasy") in 5-HT transporter deficient mice. Mol Pharmacol 53:649-655.
53. Sata R, et al. (2005) Functional analysis of organic cation transporter 3 expressed in human placenta. J Pharmacol Exp Ther 315:888-895.
54. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal Biochem 72:248-254.
55. Franklin KBJ, Paxinos G (1997) The Mouse Brain in Stereotaxic Coordinates. (Academic, Sydney).
56. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl) 85:367-370.